Here are six insights:
1. Dr. Rabchevsky is researching avenues to promote tissue sparing to enhance functional recovery. He is also looking for ways to prevent aberrant neuronal regeneration that results in hypertension.
2. Both complications following spinal cord injuries involve the dysfunction of mitochondria.
3. Dr. Rabchevsky and his team are testing pharmacological agents as mitochondria stabilizers, which could increase neuroprotection.
4. After SCI, regeneration often occurs, but establishes improper connections. This may result in autonomic dysreflexia, which involves a stimulus below the SCI causing sustained hypertension.
5. Dr. Rabchevsky has a grant to test healthy mitochondria in animals with SCI.
6. He earned his doctorate degree in neuroscience from Gainesville-based University of Florida.
More articles on spine:
Tackling variation in spine: Why are there so many ways to treat the same patient?
6 ways data impacted standard of spine care
5 key notes on new spine surgery reimbursement models
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.